12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet [Levbid]
RxNorm concept 1046771, branded drug (sbd). Prescribable name: Levbid 0.375 MG 12HR Extended Release Oral Tablet.
- RxCUI
- 1046771
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1046771 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
12 HR Levbid 0.375 MG Extended Release Oral Tablet; Levbid (hyoscyamine sulfate 0.375 MG) 12 HR Extended Release Oral Tablet; Levbid 0.375 MG 12 HR Extended Release Oral Tablet
Related concepts
- hyoscyamine sulfate 0.375 MG (SCDC, consists of)
- hyoscyamine sulfate 0.375 MG [Levbid] (SBDC, consists of)
- Extended Release Oral Tablet (DF, has dose form)
- Levbid (BN, has ingredient)
- 12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet (SCD, tradename of)
Linked data
NDCs
- 00247177206
- 00247177210
- 68220011510
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1046771 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1046771 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1046771. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.